Geron Corporation - Common Stock - Bilanço (NASDAQ:GERN)

Financials

Toplam varlıklar 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Toplam yükümlülükler 59.78 M99.62 M110.58 M146.13 M313.46 M344.67 M Toplam özsermaye 210.95 M126.42 M80 M247.95 M280.32 M225.87 M Toplam yükümlülükler ve hissedarların özsermayesi 270.73 M226.03 M190.57 M394.08 M593.78 M570.54 M Toplam borç 24.04 M49.83 M51.16 M81.94 M165.37 M119.55 M Net borç 24.04 M49.83 M51.16 M81.94 M165.37 M41.99 M

Geron Corporation - Common Stock

Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.

GERN

Financials

Geron Corporation - Common Stock

Haberler

Geron (GERN) Loses 21.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Geron Corporation (GERN) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Geron’un 1Ç 2026 sonuçları: Gelir arttı, hisse yükseldi

Geron (GERN) Reports Q1 Loss, Beats Revenue Estimates

Geron, Timothy Williams’ı hukuk müdürü olarak atadı

Geron yönetim kuruluna iki yeni üye atadı

Geron Barclays Sağlık Konferansı’nda: Stratejik Büyüme ve Planlar

Geron at Barclays Healthcare Conference: Strategic Growth and Future Plans

Geron Corporation (GERN) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Can Reblozyl Stabilize BMY's Top Line Amid Legacy Drugs Decline?

Geron TD Cowen’da: Stratejik Büyüme ve Pazar Genişlemesi

Geron at TD Cowen: Strategic Growth and Market Expansion